18f-lbt-999

18F-LBT-999 is a fluorine-18 labeled radiopharmaceutical developed by the Institut National de la Santé et de la Recherche Médicale (INSERM) for use in positron emission tomography (PET) imaging. It is a tropane derivative that functions as a high-affinity and selective ligand for the dopamine transporter (DAT), a protein located on the presynaptic terminals of dopaminergic neurons. By binding to DAT, 18F-LBT-999 allows for the non-invasive visualization and quantification of dopaminergic innervation in the brain, particularly within the striatum. This imaging agent is primarily utilized in the clinical evaluation of Parkinson's disease and other parkinsonian syndromes to assess the loss of dopaminergic neurons, aiding in early diagnosis and the monitoring of disease progression. Its favorable kinetics and high signal-to-noise ratio make it a potent tool for neuroimaging research and clinical diagnostics.

Brand names

[18F] LBT-999

Other names

8-((E)-4-fluorobut-2-enyl)-3beta-p-tolyl-8-azabicyclo[3.2.1]octane-2beta-carboxylic acid methyl esterFluorine-18 LBT-999Fluorine18 LBT-999Fluorine 18 LBT-999